Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

317
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
317
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of antibiotic, probiotic, and FMT in modulating Immunotherapy Efficacy and Survival: a systematic review and meta-analysis of clinical outcomes.

The oncologist·2026
Same author

Dual role of intratumoral microbiota: From colorectal cancer progression to therapeutic opportunities.

Journal of translational internal medicine·2026
Same author

Unraveling cross-scale driving mechanisms of ecosystem services trade-offs for metropolitan sustainable management: Insight from a three-level hierarchical linear model.

Journal of environmental management·2026
Same author

Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.

Archivos de bronconeumologia·2026
Same author

Decoding nucleic acid modification regulatory networks: A key to cancer intervention and treatment.

Physics of life reviews·2026
Same author

Increased precipitation partially alleviates the carbon-water tradeoff under the Grain for Green program.

Environmental research·2026

Related Experiment Video

Updated: Jun 1, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K

Computational frameworks transform antagonism to synergy in optimizing combination therapies.

Jinghong Chen1,2, Anqi Lin1, Aimin Jiang3

  • 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

NPJ Digital Medicine
|January 19, 2025
PubMed
Summary

Predicting drug combination effects is difficult but crucial for disease treatment. This review analyzes computational methods and artificial intelligence for better prediction using multi-omics data.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

Related Experiment Videos

Last Updated: Jun 1, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Bioinformatics

Background:

  • Drug combinations are vital for treating complex diseases.
  • Predicting synergistic and antagonistic drug interactions remains a significant challenge.
  • Multi-omics data integration offers a promising avenue for improving prediction accuracy.

Purpose of the Study:

  • To systematically review computational methods for predicting drug combination effects.
  • To evaluate algorithms and data integration approaches for drug synergy prediction.
  • To highlight the role of artificial intelligence in this field.

Main Methods:

  • Systematic analysis of computational prediction methods.
  • Assessment of key algorithms like DrugComboRanker and AuDNNsynergy.
  • Evaluation of multi-omics data integration techniques, including kernel regression and graph networks.

Main Results:

  • Identified and assessed various computational strategies for drug combination effect prediction.
  • Demonstrated the utility of multi-omics data integration in enhancing predictive models.
  • Highlighted the application of artificial intelligence for predicting drug synergy and antagonism.

Conclusions:

  • Computational methods, particularly those leveraging multi-omics data and AI, are essential for advancing drug combination therapy.
  • Further development and validation of these methods are needed to overcome prediction challenges.
  • This review provides a comprehensive overview to guide future research in predictive drug combination studies.